PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Desitin Pharma Ltd
DP

Desitin Pharma Ltd

Woking
SME

Desitin Pharma Ltd is the UK affiliate of Desitin Arzneimittel GmbH, a specialist pharmaceutical company focused on formulations of anti-seizure medications.

desitin.co.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£424.3m
Live
16
Buyers
6
12m
£403.7m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts16 / 19
  • Top buyers6
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Desitin Pharma LtdUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Desitin Pharma Ltd has won £424.3m across 6 public-sector buyers, with 16 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 100% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
16 of 19Live contracts
100%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 7
Desitrend®Levetiracetam ↗Desizon®Zonisamide ↗DiazepamDiazepam ↗Enodama®Primidone ↗Episenta®Sodium Valporate ↗LamotrigineLamotrigine ↗Ospolot®Sulthiame ↗

Extracted automatically from desitin.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 16 live · 3 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS National Generic Pharmaceuticals Wave 14a
NHS England3360000001 Feb 2023£2.1m2 yrsClosed
NHS Framework Agreement for Branded Medicines - National
NHS England3360000001 May 2019£18.5m2 yrsClosed
NHS National Generic Pharmaceuticals - Wave 15c
NHS England————Live
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Procurement and Logistics Service, Business Services Organisation————Live
NHS National Generic Pharmaceuticals Wave 15b
NHS England33600000———Live
Generic, Branded Generic & Proprietary Medicinal Products - Group 14
Procurement and Logistics Service33600000———Live
Generic Drugs - Injections/Infusions
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)————Live
NHS National Generic Pharmaceuticals Wave 14c
NHS England33600000———Live
Total live value £0.02 · mean award £22.3m1–10 of 19

Top buyers · 6 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
11 contracts
100%
since 2019
2
Procurement and Logistics Service, Business Services Organisation
1 contract
0%
3
Procurement and Logistics Service
1 contract
0%
4
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
3 contracts
0%
5
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
2 contracts
0%
6
The NHS Commissioning Board (operating under the name of NHS England)
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire11 contracts
100%
Northern Ireland2 contracts
0%
Wales3 contracts
0%
Scotland2 contracts
0%
North West1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Desitin Pharma Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
DP
Desitin Pharma Ltd
Yes£403.7m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Due in -10d
Next due 30 Jun 2026
Confirmation statement
Up to date
Next due 21 Nov 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
07914851
Status
Active
Type
Private limited
Incorporated
18 Jan 2012
Reg. office
6 Hermitage Road, Woking, Surrey, GU21 8TB
SIC codes
46460
Last accounts
30 Sept 2024
Next accounts due
30 Jun 2026

Directors & PSC

  • BLOCHING, Philipp Andreas — director
    Appointed 01 Jul 2022
  • THIEKEN, Katrin Elisabeth — director
    Appointed 01 Jul 2022
  • STEWART, Andrew David — director
    Appointed 29 Jan 2021
  • Jonas Nikolaus Rommig — person with significant control
    voting rights 25 to 50 percent
  • Desitin Arzneimittel Gmbh — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
DESITIN PHARMA LIMITED
07914851 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.